Advanced Biomedical Technologies

Advanced Biomedical Technologies Market capitalization

The The market capitalization of Advanced Biomedical Technologies (ABMT) as of Nov 22, 2026 is 10,000.00 USD. In the previous year, The market capitalization was 10,000.00 USD — a change of 0.00% (lower).

Market capitalization

10,000.00USD

YoY

0.00%

Last updated:

In 2022, Advanced Biomedical Technologies's market cap stood at 10,000.00 USD, a 0.00% increase from the 10,000.00 USD market cap in the previous year.

The Advanced Biomedical Technologies Market capitalization history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Market capitalization
Date
Market capitalization
Jan 1, 2015
10,000.00 USD
Jan 1, 2016
10,000.00 USD
Jan 1, 2017
10,000.00 USD
Jan 1, 2018
10,000.00 USD
Jan 1, 2019
10,000.00 USD
Jan 1, 2020
10,000.00 USD
Jan 1, 2021
10,000.00 USD
Jan 1, 2022
10,000.00 USD
The Advanced Biomedical Technologies Market capitalization history
YEARMarket capitalizationYoY
10,000.00USD0.00%
10,000.00USD0.00%
10,000.00USD0.00%
10,000.00USD0.00%
10,000.00USD0.00%
10,000.00USD0.00%
10,000.00USD0.00%
10,000.00USD0.00%
10,000.00USD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Advanced Biomedical Technologies Stock analysis

What does Advanced Biomedical Technologies do? Advanced Biomedical Technologies Inc is an innovative biomedical company specializing in the development of advanced medical devices and technologies. The company was founded in 1985 by an experienced team of biotech experts and is headquartered in California, USA. History: The company's roots lie in the research and development of novel medical implants and prosthetics. However, over the years, the company has quickly evolved into a leading provider of medical devices and technologies in the fields of diagnostics, therapy, and care. Business model: The business model of Advanced Biomedical Technologies Inc is focused on providing innovative and advanced solutions for medical care. The company strives to continuously develop its products and help customers achieve their healthcare goals. Divisions: The company is divided into four main divisions focusing on different medical areas: 1) Interventional Cardiology: Here, the company develops devices for the treatment of heart diseases, such as stents for reopening narrowed vessels. 2) Orthopedics: Another focus is on the development of innovative orthopedic implants and prosthetics that help patients regain their mobility and improve their quality of life. 3) Oncology: In this division, the company works on the development of medical devices and systems for the diagnosis and treatment of cancer. 4) Neurology: Here, the company focuses on the development of medical technologies and devices for the diagnosis and treatment of nervous system disorders, such as Parkinson's or Alzheimer's. Products: Advanced Biomedical Technologies Inc's products include a variety of medical devices and technologies specialized in different medical areas. Some of the company's most well-known products are: - Stents for reopening narrowed vessels in the heart - Artificial joints and implants for restoring mobility and quality of life - Medical devices for the diagnosis and treatment of cancer - Neurostimulation devices for the treatment of chronic pain and other neurological disorders - Robot-assisted surgery systems that assist surgeons in complex procedures. Conclusion: Advanced Biomedical Technologies Inc is a leading biomedical company specializing in the development of advanced medical devices and technologies. The company has a long history in the research and development of medical implants and prosthetics but has quickly expanded into a broader range of medical applications. With its focus on developing innovative products for patients' quality of life, Advanced Biomedical Technologies Inc will continue to play an important role in medical innovation. Advanced Biomedical Technologies is one of the most popular companies on Eulerpool.

Market capitalization Details

Exploring Advanced Biomedical Technologies's Market Capitalization

Advanced Biomedical Technologies's market capitalization represents the total dollar market value of the company’s outstanding shares of stock. It is calculated by multiplying the company's shares outstanding by the current market price of one share. This metric is a vital indicator of a company’s size, strength, and overall market value.

Year-to-Year Comparison

A yearly comparison of Advanced Biomedical Technologies's market capitalization provides investors and analysts insights into its growth and valuation trends. An increase signifies market confidence and business expansion, while a decrease may point towards declining market value or business contractions.

Impact on Investments

Advanced Biomedical Technologies's market capitalization plays a pivotal role in investment decisions. It aids investors in assessing the company's risk and return profiles. Larger companies are often considered more stable but may offer lower growth potential, while smaller companies might offer significant growth prospects but come with higher risk.

Interpreting Market Capitalization Fluctuations

Variations in Advanced Biomedical Technologies’s market capitalization can be attributed to several factors, including changes in stock price, outstanding shares, and market sentiment. Understanding these fluctuations helps investors evaluate the company's current standing and future potential in the competitive landscape.

Frequently Asked Questions about Advanced Biomedical Technologies stock

The market capitalization of Advanced Biomedical Technologies is 10,000.00 USD in 2022.

The market capitalization of Advanced Biomedical Technologies changed from 10,000.00 USD to 10,000.00 USD, representing a 0.00% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of The market capitalization Advanced Biomedical Technologies since 2006 – with annual values, charts, and detailed analysis.

Market capitalization (German: Market capitalization, English: market capitalisation or market cap) is the calculated total value of all shares of a publicly traded company. The market capitalization of a company reflects the current market consensus on the value of the equity of a publicly traded company. It is determined by the supply and demand for the company's shares. Thus, market capitalization is significantly influenced by expectations in the stock market regarding the future earnings power of the company and, therefore, can be subject to significant fluctuations.

Number of shares * share price = market capitalization

To evaluate The market capitalization's USD, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for The market capitalization.

A 'good' USD varies by industry and company stage. On Eulerpool, you can compare The market capitalization's Advanced Biomedical Technologies with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — Advanced Biomedical Technologies

All Key Metrics — Advanced Biomedical Technologies